These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 1949846)
41. [Replacement therapy with blood components in bone-marrow depression due to cytostatic drugs (author's transl)]. Höcker P; Pittermann E; Mann M; Krasa E Wien Klin Wochenschr; 1980 Aug; 92(15):530-5. PubMed ID: 7001766 [TBL] [Abstract][Full Text] [Related]
42. [Thrombocyte collection with the cell separator. Determination of status and perspectives]. Müller V; Borberg H Beitr Infusionther Klin Ernahr; 1986; 15():58-65. PubMed ID: 3753414 [No Abstract] [Full Text] [Related]
43. [Washing and filtration of blood components: which indications are established?]. Neppert J Beitr Infusionsther; 1993; 31():64-9. PubMed ID: 7693266 [TBL] [Abstract][Full Text] [Related]
44. [Allogeneic hematopoietic stem-cell transplantation for hematological malignancies]. Michallet M; Dhedin N; Michallet AS Bull Cancer; 2001 Sep; 88(9):908-26. PubMed ID: 11604365 [TBL] [Abstract][Full Text] [Related]
45. Leucocyte depletion of blood components. Bird A S Afr Med J; 2001 Oct; 91(10):822-3. PubMed ID: 11732450 [No Abstract] [Full Text] [Related]
46. Current trends: evolving concepts in transfusion medicine. Leukoreduced blood components: "you can filter now or you can filter later.". Dzik WH Transfus Sci; 1992 Apr; 13(2):207-10. PubMed ID: 10148127 [No Abstract] [Full Text] [Related]
49. Strategies for elective red blood cell transfusion. Ross JM Ann Intern Med; 1992 Sep; 117(5):441; author reply 442. PubMed ID: 1503338 [No Abstract] [Full Text] [Related]
50. Integrating the new generation of blood components into transfusion practice. Ness PM Transfusion; 1999 Sep; 39(9):1027-30. PubMed ID: 10533831 [No Abstract] [Full Text] [Related]
51. Correction of the corrected count increment units. Brubaker DB Transfusion; 1993 Apr; 33(4):358-9. PubMed ID: 8480359 [No Abstract] [Full Text] [Related]
52. Single versus double-unit transfusion policy in hematology. Tendas A; Niscola P; Cupelli L; Scaramucci L; Giovannini M; de Fabritiis P Haematologica; 2012 Jul; 97(7):e25. PubMed ID: 22798546 [No Abstract] [Full Text] [Related]
53. Guidelines: the same evidence but different conclusions - relaxation of indications for irradiation of cellular blood components? Bolton-Maggs PHB Br J Haematol; 2021 Dec; 195(5):657-659. PubMed ID: 34580861 [No Abstract] [Full Text] [Related]
54. [Vascular components in the clinical aspect of epilepsy]. FORSTER E Dtsch Med Wochenschr; 1951 Jun; 76(22):732-4. PubMed ID: 14849394 [No Abstract] [Full Text] [Related]
57. [Supportive therapy with blood components]. Höcker P Wien Med Wochenschr; 1991; 141(9-10):209-12. PubMed ID: 1949846 [TBL] [Abstract][Full Text] [Related]
59. Current trends in blood component therapy: the evolution of a safer, more effective product. Baranowski L J Intraven Nurs; 1992; 15(3):136-51. PubMed ID: 1608013 [TBL] [Abstract][Full Text] [Related]
60. Therapeutic efficacy of pooled buffy-coat platelet components prepared and stored with a platelet additive solution. van Rhenen DJ; Gulliksson H; Cazenave JP; Pamphilon D; Davis K; Flament J; Corash L Transfus Med; 2004 Aug; 14(4):289-95. PubMed ID: 15285725 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]